Development of vaccines against burkholderia pseudomallei.


Patel, N; Conejero, L; De Reynal, M; Easton, A; Bancroft, GJ; Titball, RW; (2011) Development of vaccines against burkholderia pseudomallei. Front Microbiol, 2. p. 198. ISSN 1664-302X DOI: 10.3389/fmicb.2011.00198

[img]
Preview
Text - Published Version
License:

Download (465Kb) | Preview

Abstract

Burkholderia pseudomallei is a Gram-negative bacterium which is the causative agent of melioidosis, a disease which carries a high mortality and morbidity rate in endemic areas of South East Asia and Northern Australia. At present there is no available human vaccine that protects against B. pseudomallei, and with the current limitations of antibiotic treatment, the development of new preventative and therapeutic interventions is crucial. This review considers the multiple elements of melioidosis vaccine research including: (i) the immune responses required for protective immunity, (ii) animal models available for preclinical testing of potential candidates, (iii) the different experimental vaccine strategies which are being pursued, and (iv) the obstacles and opportunities for eventual registration of a licensed vaccine in humans.

Item Type: Article
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Immunology and Infection
Faculty of Infectious and Tropical Diseases > Dept of Pathogen Molecular Biology
Research Centre: Vaccine Centre
PubMed ID: 21991263
Web of Science ID: 208863500206
URI: http://researchonline.lshtm.ac.uk/id/eprint/18664

Statistics


Download activity - last 12 months
Downloads since deposit
285Downloads
319Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item